文献速递流行病学与生物统计医学教育与科研方法

开发鳞状细胞癌临床试验核心结局指标集:系统文献综述与德尔菲调查识别核心结局指标集的研究方案

Development of a core outcome set for clinical trials in squamous cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
PubMed 文献 · Trials · 2017-07-12

本方案旨在为鳞状细胞癌(SCC)临床试验开发核心结局指标集(COS)。通过系统文献综述、患者访谈、其他已发表来源及利益相关者输入四种方法提取结局,经IMPROVED指导委员会重新评估,由专家临床医生和患者分别进行德尔菲流程精简结局,随后召开共识会议投票确定最终推荐的核心结局集,COMET和CSG-COUSIN全程提供咨询。

要点

  • SCC临床试验结局报告异质性大、常被省略或与临床无关,影响研究间比较。
  • COS是建议在所有临床试验中测量和报告的最小结局集合,SCC尚无特异性COS。
  • 本方案通过四种方法提取结局,经德尔菲调查和共识会议确定最终推荐COS。

核心结论

  • 本项目旨在开发一个COS,以指导未来SCC临床试验的结局选择。

研究设计与样本

  • 研究方案:通过系统文献综述、患者访谈、其他已发表来源及医学、药学和其他相关行业利益相关者输入四种方法提取结局。
  • 由IMPROVED指导委员会重新评估结局列表,专家临床医生和患者分别进行德尔菲流程精简结局,随后召开共识会议投票确定最终推荐核心结局集。
  • COMET组织和CSG-COUSIN在整个COS生成过程中担任顾问。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Squamous cell carcinoma (SCC) is a common skin cancer that poses a risk of metastasis. Clinical investigations into SCC treatment are common, but the outcomes reported are highly variable, omitted, or clinically irrelevant. The outcome heterogeneity and reporting bias of these studies leave clinicians unable to accurately compare studies. Core outcome sets (COSs) are an agreed minimum set of outcomes recommended to be measured and reported in all clinical trials of a given condition or disease. Although COSs are under development for several dermatologic conditions, work has yet to be done to identify core outcomes specific for SCC. METHODS/DESIGN: Outcome extraction for COS generation will occur via four methods: (1) systematic literature review; (2) patient interviews; (3) other published sources; and (4) input from stakeholders in medicine, pharmacy, and other relevant industries. The list of outcomes will be revaluated by the Measuring PRiority Outcome Variables via Excellence in Dermatologic surgery (IMPROVED) Steering Committee. Delphi processes will be performed separately by expert clinicians and patients to condense the list of outcomes generated. A consensus meeting with relevant stakeholders will be conducted after the Delphi exercise to further select outcomes, taking into account participant scores. At the end of the meeting, members will vote and decide on a final recommended set of core outcomes. The Core Outcome Measures in Effectiveness Trials (COMET) organization and the Cochrane Skin Group - Core Outcome Set Initiative (CSG-COUSIN) will serve as advisers throughout the COS generation process. DISCUSSION: Comparison of clinical trials via systematic reviews and meta-analyses is facilitated when investigators study outcomes that are relevant and similar. The aim of this project is to develop a COS to guide use for future clinical trials.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Schlessinger DI, Iyengar S, Yanes AF, et al. Development of a core outcome set for clinical trials in squamous cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey. Trials. 2017. PMID: 28701207. doi:10.1186/s13063-017-2069-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。